Obviousness

Analysis of Obviousness under 35 U.S.C. § 103

This analysis evaluates whether the invention described in U.S. Patent No. 11,969,333 ("the '333 patent") would have been obvious to a Person of Ordinary Skill in the Art (POSITA) at the time the invention was made. The analysis focuses on independent claims 1 and 12, which define the core of the patented system and method.

A POSITA in this field would likely be an engineer or scientist with experience in designing and developing endovascular medical devices, particularly those for thrombectomy and aspiration, possessing knowledge of fluid dynamics and materials used in catheter-based systems.

Summary of Independent Claims

• Claim 1 (System): Describes a clot removal system with an aspiration catheter, a collection canister, a suction source (e.g., a syringe of at least 60 mL), and a connecting tube. The key limitations are the tube's dimensions: an inner diameter of at least 0.25 inches and a length of no more than 48 inches.
• Claim 12 (Method): Describes a method using a similar system, emphasizing the step of pre-charging a vacuum in the suction source and then opening a valve to apply suction. A critical feature of the claimed method is that the pressure in the system equalizes in less than one second, resulting in a rapid, high-velocity aspiration.

Potential Combination of Prior Art

The claims of the '333 patent appear vulnerable to an obviousness rejection based on a combination of prior art references that teach all the claimed elements and provide a motivation to combine them. A potential combination could involve a primary reference disclosing a basic aspiration thrombectomy system and secondary references teaching the specific modifications related to component dimensions and the pre-charging technique.

Primary Reference: A General Aspiration Thrombectomy System

The concept of using a catheter connected to a suction source to aspirate a thrombus is well-established in the prior art. For example, systems like those described in patents for general-purpose aspiration or earlier thrombectomy devices would teach the fundamental combination of a catheter, tubing, a collection canister, and a syringe or vacuum pump. These references establish the basic framework of the claimed invention.

Secondary References and Motivation to Combine

The inventive thrust of the '333 patent lies in the specific configuration that enables rapid, high-force aspiration. The obviousness argument would hinge on whether a POSITA would have been motivated to modify a standard aspiration system to include the specific features of the '333 patent to achieve this known goal.

1. Large-Bore Components for Increased Flow:

   • Prior Art Teaching: The field of thrombectomy, particularly for large-vessel occlusions like pulmonary embolism, has long recognized the need for large-bore catheters to remove significant clot burden efficiently. Devices like the Penumbra Indigo® System (and its related patents, such as U.S. Pat. No. 9,095,384) emphasize the principle of maximizing the aspiration lumen to improve the rate and volume of clot removal.
   • Motivation to Combine: A POSITA, seeking to improve the efficacy of a standard aspiration system, would understand from basic principles of fluid dynamics (e.g., Poiseuille's law) that flow rate is proportional to the fourth power of the radius. To maximize suction force and clot retrieval, it would have been an obvious and logical step to increase the diameter of not only the catheter but also any component in the fluid path that could create a bottleneck. Therefore, modifying the connecting tubing to have a large inner diameter (such as at least 0.25 inches) to match the large-bore catheter would be a straightforward design choice to minimize flow resistance.

2. Short Tubing Length for System Responsiveness:

   • Prior Art Teaching: In any vacuum-based system, it is a known engineering principle that minimizing the "dead space" volume between the vacuum source and the point of application increases the speed at which the vacuum takes effect.
   • Motivation to Combine: A POSITA would recognize that a long tube would increase the total volume that needs to be evacuated, thereby delaying the application of maximum suction at the catheter tip and dissipating the vacuum's energy. To create the most immediate and forceful "water hammer" effect for dislodging a clot, a POSITA would be motivated to keep the tubing as short as practically possible within a clinical setting. Limiting the length to 48 inches or less is an obvious design choice to keep the suction source within the sterile field and easily accessible to the operator, thereby improving system responsiveness.

3. Pre-Charged, Large-Volume Syringe for Rapid Suction:

   • Prior Art Teaching: The technique of pre-charging a vacuum in a syringe and then releasing it to generate a rapid burst of suction is a known method. The '333 patent itself describes a commercially available "VacLok" syringe (FIG. 2) that can generate and hold a vacuum. These locking syringes were available long before the priority date of the '333 patent and were used for various medical aspiration procedures. Furthermore, using large-volume syringes (60 mL or greater) is standard practice for procedures requiring significant fluid aspiration.
   • Motivation to Combine: A POSITA would be motivated to use a pre-charged vacuum source to create a more powerful initial suction force compared to what could be generated by simply pulling back on a syringe plunger in real-time. This initial high-velocity flow would be desirable for breaking the clot's adhesion to the vessel wall and capturing it within the catheter's distal tip before it can fragment and embolize downstream. Combining this known technique with a large-bore, short-tube system would be a logical step to maximize this effect. The claimed result—pressure equalization in less than one second—is not an independent inventive step but rather the expected and predictable outcome of combining these known, high-flow components with a pre-charged vacuum source.

Conclusion on Obviousness

The system and method claimed in U.S. Patent No. 11,969,333 represent a combination of elements that were individually known in the art. A person of ordinary skill, when faced with the problem of removing large and organized thrombi, would have been motivated to design a system with a low-resistance, high-flow aspiration pathway. This would have led them to select a large-bore catheter and to match it with large-bore, short-length tubing to avoid flow limitations. To effectively dislodge and capture the clot, they would have been motivated to use a pre-charged, large-volume vacuum source to generate a rapid and powerful initial suction force. The combination of these known elements for their predictable results would render the invention as claimed in independent claims 1 and 12 obvious under 35 U.S.C. § 103. The specific dimensions and performance characteristics recited appear to be the result of routine design optimization rather than a non-obvious inventive contribution.